ImaBiotech
Business Services · France · 11-50 Employees
View Company Info for Free
Overview
Headquarters
152 Rue Du Docteur Yersin, Loos, Hauts-d...Phone Number
+33 320164091Website
www.imabiotech.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About ImaBiotech
ImaBiotech is a Contract Research Organization (CRO) with facilities in Boston (MA, USA) and Lille (Eurasant Parc, France). The company offers innovative services and software to the pharmaceutical research sector, providing highly in vivo informative drug efficacy and toxicity evaluations during preclinical and clinical stage developments at cellular level, making better and safer drugs. Services are based on histology combined to label free molecular imaging (Quantitative Mass Spectrometry Imaging, QMSI) a technology developed and constantly improved by ImaBiotech. QMSI is a game changer for the pharmaceutical industry in all therapeutic areas. While other techniques provide global information, this molecular technique provides a deeper understanding of a drugs localization and its pharmacological effects at cellular level. This improves the interpretation of drug efficacy and toxicity, resulting in better drugs and decreasing time-to-market.Explore more
ImaBiotech Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is ImaBiotech your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on ImaBiotech recently announced quarterly report
Check if ImaBiotech has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at ImaBiotech
Funding: Get notified immidiatlly once ImaBiotech has new funding data
ImaBiotech, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if ImaBiotech had a recent Job posting/layoffs
Check out if ImaBiotech is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when ImaBiotech launches new products
Recommended Actions
Reach out to Masked Content who joined ImaBiotech as Masked Content
Find 2 more new buyers
Compare Similar Companies to ImaBiotech
Compare insights from companies similar to ImaBiotech, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
ImaBiotech is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
ImaBiotech is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about ImaBiotech.
ImaBiotech Tech Stack
A closer look at the technologies used by ImaBiotech
See more technologies
ImaBiotech News & Media
ImaBiotech Supports the Institut Pasteur de Lille and Apteeus for the...
ImaBiotech, the worldwide leading provider of innovative imaging services joined the fight against the Covid19 by putting its expertise at the service of the drug candidate TEE001 currently in... (PRWeb June 28, 2021) Read the full story at https://www.prweb.com/releases/imabiotech_supports_the_institut_pasteur_de_lille_and_apteeus_for_the_development_of_covid_19_therapy/prweb18027687.htmImaBiotech poursuit son développement aux Etats-Unis avec l’acquisition de Pyxant Labs à Colorado Springs et Salt Lake City
LILLE, France et BOSTON et COLORADO SPRINGS, Colo.--(BUSINESS WIRE)--ImaBiotech annonce aujourd'hui la création d'un groupe international de prestation de services d’excellence pour la recherche pharmaceutique avec la société Pyxant Labs Inc. (« Pyxant ») basé à Colorado Springs (Colorado, USA) et à Salt Lake City (Utah, USA). Le groupe offrira des solutions de développement de médicaments uniques et innovantes aux entreprises pharmaceutiques et cosmétiques. En combinant à la fois innovation etImaBiotech Expands Bioanalytical Pharmaceutical Services in North America with Pyxant Labs Colorado and Salt Lake City Sites
LILLE, France & BOSTON & COLORADO SPRINGS, Colo.--(BUSINESS WIRE)--ImaBiotech Group today announced the creation of an innovative global bioanalytical CRO with Pyxant Labs Inc. Colorado Springs and Salt Lake City sites. The integration of the expertise, innovation and analytical platforms of the companies to form a leading global bioanalytical services provider will provide a unique offering to pharmaceutical and cosmetic companies. Encompassing unique proprietary drug and biomarker imaging (MaAbstract accepted for poster presentation at the International Investigative Dermatology Conference in Orlando, May 16-19 2018
Follicum AB (“Follicum” or “the Company”) a clinical stage company focused on developing a novel peptide to promote hair growth, today, May 7, announces that an abstract has been accepted for poster presentation during the International Investigative Dermatology Conference to be held in Orlando, USA May 16-19 2018. The abstract will be presented by Follicum´s partner, ImaBiotech - a CRO with innovative imaging services. The details of the abstract can be found below. Poster session: Poster
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding ImaBiotech
Sign Up For FreeTo access detailed company insights
ImaBiotech is a Contract Research Organization (CRO) with facilities in Boston (MA, USA) and Lille (Eurasant Parc, France). The company offers innovative services and software to the pharmaceutical research sector, providing highly in vivo informative drug efficacy and toxicity evaluations during preclinical and clinical stage developments at cellu... Read More
